Biopharmaceuticals
Litigation
Licensing
News Release - October 18, 2018
AbbVie Announces Global Resolution of HUMIRA(R) (adalimumab) Patent Disputes with Fresenius Kabi
Source: AbbVie
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.